Brief: Ovid Therapeutics Announces Pricing Of $60 Million Private Placement
March 18 (Reuters) - Ovid Therapeutics Inc OVID.O: OVID THERAPEUTICS ANNOUNCES PRICING OF $60 MILLION PRIVATE PLACEMENT Source text: ID:nGNX9j7rTm Further company coverage: OVID.O ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Ovid Therapeutics
See all newsOvid Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Ovid Therapeutics Q2 revenue beats estimates
Brief: Ovid Therapeutics Q2 EPS USD -0.08
Ovid Therapeutics Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Ovid Therapeutics Appoints Leading Physician-Scientist And Biotech Innovator Anna Greka, M.D., Ph.D., To Board Of Directors